Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related protein

Annals of Neurology

Volumn 37, Issue 2, 1995, Pages 211-217

  Rebeck, G William ^a   Harr, Steven D ^a   Hyman, Bradley T ^a   Strickland, Dudley K ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; RECEPTOR BINDING; SENILE PLAQUE;

ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; HIPPOCAMPUS; HUMAN; LDL-RECEPTOR RELATED PROTEIN 1; LIGANDS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028894661     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410370212     Document Type: Article

References (52)

1. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein
2. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell‐surface receptor
3. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
4. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus
5. Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid‐like fibrils in vitro
6. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
7. Amyloid β‐peptide is produced by cultured cells during normal metabolism
8. Isolation and quantification of soluble Alzheimer's β‐peptide from biological fluids
9. Production of the Alzheimer amyloid β protein by normal proteolytic processing
10. Yankner BA. Generation of β‐amyloid in the secretory pathway in neuronal and non‐neuronal cells
11. Alzheimer's disease: a description of the structural lesions
12. α1‐Trypsin immunoreactivity in Alzheimer disease
13. Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
14. α2‐Macroglobulin expression in neuritic‐type plaques in patients with Alzheimer's disease
15. Immunochemical identification of the serine protease inhibitor α1‐antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
16. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study
17. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Kreutzfeldt‐Jakob disease
18. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
19. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions
20. Increased amyloid β‐peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late‐onset Alzheimer disease
21. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain
22. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease
23. Apolipoprotein E: high‐avidity binding to β‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease
24. Association of apolipoprotein E allele ε4 with late‐onset familial and sporadic Alzheimer's disease
25. Apolipoprotein E polymorphism and Alzheimer's disease
26. Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease
27. Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease
28. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
29. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform‐specific effects and implications for late‐onset Alzheimer disease
30. Lipoproteins and their receptors in the central nervous system
31. Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization
32. Characterization and immunohistochemical localization of α2‐macroglobulin receptor (low‐density lipoprotein receptor‐related protein) in human brain
33. Distribution of the α2‐macroglobulin receptor/low density lipoprotein receptor‐related protein in human tissues
34. Immunohistochemical study of α2‐macroglobulin receptor in Alzheimer and control postmortem human brain
35. Surface location and high affinity for calcium of a 500‐kd liver membrane protein closely related to the LDL‐receptor suggest a physiological role as lipoprotein receptor
36. Proteolytic processing of the 600kd low density lipoprotein receptor‐related protein (LRP) occurs in a trans‐Golgi compartment
37. Low density lipoprotein receptor‐related protein mediates uptake of cholesteryl esters derived from apoprotein E‐enriched lipoproteins
38. Sequence identity between the α2‐macroglobulin receptor and low density lipoprotein receptor‐related protein suggests that this molecule is a multifunctional receptor
39. Analysis of ligand recognition by the purified α2‐macroglobulin receptor (low density lipoprotein receptor‐related protein)
40. Low density lipoprotein receptor‐related protein and gp330 bind similar ligands, including plasminogen activator‐inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance
41. The LDL‐receptor‐related protein, LRP, is an apolipoprotein E‐binding protein
42. Low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor is a hepatic receptor for tissue‐type plasminogen activator
43. Low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor mediates cellular uptake of pro‐urokinase
44. Purified α2‐macroglobulin receptor/LDL receptor‐related protein bind urokinase‐plasminogen activator inhibitor type‐1 complex
45. Complexes of tissue‐type plasminogen activator and its serpin inhibitor plasminogenactivator inhibitor type 1 are internalized by means of the low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor
46. A novel mechanism for controlling the activity of α2‐macroglobulin receptor/low density lipoprotein receptor‐related protein
47. 39‐kDa protein modulates binding of ligands to low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor
48. Differential distribution of lactoferrin and Alz‐50 immunoreactivities in neuritic plaques and neurofibrillary tangles in Alzheimer's disease
49. Kunitz protease inhibitor‐containing amyloid β protein precursor immunoreactivity in Alzheimer's disease
50. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E‐containing lipoproteins
51. Cell‐derived proteases and protease inhibitors as regulators of neurite outgrowth